Lexaria Bioscience Corp. (LEXX) vs Soligenix, Inc. (SNGX)
A side-by-side comparison of Lexaria Bioscience Corp. and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LEXX
Lexaria Bioscience Corp.
$3.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SNGX
Soligenix, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LEXX vs SNGX
growth of $100 · dividends reinvested · last 6yLEXX -95.9% (-41.2%/yr)SNGX -99.9% (-68.1%/yr)LEXX compounded faster over this window
Log scale — wide-divergence pair
LEXX SNGX
LEXX vs SNGX: by the numbers
- •LEXX is the larger company ($5M vs $5M market cap).
- •Both run net losses; SNGX's is the smaller (0.00% vs -3985.58% net margin).
Metrics side by side
Valuation
| Metric | LEXX | SNGX |
|---|---|---|
| P/S ratio | 27.60 | N/A |
| P/B ratio | 1.13 | 0.80 |
Profitability
| Metric | LEXX | SNGX |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -1683.01% | 0.00% |
| Net margin | -3985.58% | 0.00% |
| ROE | -163.18% | -154.08% |
| ROIC | -175.26% | -161.69% |
Growth (annualized)
| Metric | LEXX | SNGX |
|---|---|---|
| Revenue CAGR (5Y) | 12.92% | N/A |
| Total return CAGR (5Y) | -50.86% | -72.72% |
Frequently asked
- How have LEXX and SNGX total returns compared?
- Over the past 5 years, LEXX delivered -50.86% and SNGX delivered -72.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.